Department of Health and Human Services
Also known as: Agency for Healthcare Research and Quality (AHRQ) | BARDA (Biomedical Advanced Research and Development Authority) | Barda (Contract No HHSO100201300011C) | Biomedical Advanced Research and Development Authority | Biomedical Advanced Research and Development Authority BARDA (Funder) | Biomedical Advanced Research and Development Authority (BARDA) (RoW) | Department of Health and Human Services | U.S. Administration on Community Living | US Department of Health and Human Services
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2003Last known activity
Oct 16, 2025
Timeline
1950s
- Apr 11, 1953
Department of Health and Human Services— Founded
Drugs by trial phase (184 distinct, 181 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (37 own, 0 via acquisition)
Phase 2 (49 own, 0 via acquisition)
Phase 1 (72 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Studied for
- Acute Radiation Syndrome
- Alcoholic Intoxication
- Alcoholism
- Anemia
- Anemia, Aplastic
- Anemia, Neonatal
- Anemia, Sickle Cell
- Anthrax
- Asthma
- Bacteremia
- Bacterial Infections
- Bipolar Disorder
- Blood Coagulation Disorders
- Botulism
- Carcinoma
- Carcinoma, Hepatocellular
- Clostridium Infections
- Colitis
- Communicable Diseases
- Coronavirus Infections
- Cough
- Cystitis
- Diarrhea
- Disease
- Fasciitis
- Fasciitis, Necrotizing
- Fatigue
- Fournier Gangrene
- Gangrene
- Headache
- Heart Failure
- Hematologic Diseases
- Hematologic Neoplasms
- Hemorrhage
- Hemorrhagic Fever, Ebola
- Hemorrhagic Fevers, Viral
- Hemostatic Disorders
- Infections
- Influenza, Human
- Influenza in Birds
- Intraabdominal Infections
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Mouth Neoplasms
- Multiple Myeloma
- Myalgia
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasms, Plasma Cell
- Nervous System Diseases
- Neutropenia
- Osteoporosis
- Osteoporosis, Postmenopausal
- Paralysis
- Pharyngitis
- Pneumonia
- Pneumonia, Bacterial
- Pneumonia, Ventilator-Associated
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Pyelonephritis
- Radiation Injuries
- Renal Insufficiency
- Severe Acute Respiratory Syndrome
- Skin Diseases, Bacterial
- Smallpox
- Soft Tissue Infections
- Spinal Cord Injuries
- Staphylococcal Infections
- Syndrome
- Thrombocytopenia
- Urinary Tract Infections
- Vaginitis
- Wounds and Injuries
- Zika Virus Infection
Recent trials (50)
- NCT07217886CollaboratorPhase 1Oct 16, 2025
- NCT07104162CollaboratorPhase 1Sep 16, 2025
- NCT07128615CollaboratorPhase 1/Phase 2Sep 4, 2025
- NCT06925321CollaboratorPhase 3Aug 26, 2025
- NCT06919016CollaboratorPhase 1Aug 6, 2025
- NCT07001254CollaboratorPhase 2Jul 31, 2025
- NCT06905275CollaboratorPhase 1Jul 7, 2025
- NCT06803342CollaboratorPhase 2Jun 26, 2025
- NCT07035769CollaboratorPhase 1Jun 18, 2025
- NCT06961708CollaboratorPhase 1Apr 14, 2025
- NCT06860802CollaboratorPhase 1Feb 28, 2025
- NCT06938867CollaboratorPhase 1/Phase 2Feb 25, 2025
- NCT06812494CollaboratorPhase 2Feb 1, 2025
- NCT06620003CollaboratorPhase 2Jan 31, 2025
- NCT06672978CollaboratorPhase 2Jan 31, 2025
Details
- Founded
- Washington, D.C., US Apr 11, 1953
- Last known activity
- Oct 16, 2025